Riken Vitamin Co Ltd

Riken Vitamin maintains a strong liquidity position, with a current ratio of 3.11 and cash and equivalents of ¥22.3 billion, which is well above the industry median. The company's debt-to-equity ratio of 0.14 indicates a conservative capital structure, with long-term debt of ¥11.1 billion compared to total equity of ¥79.2 billion. Profitability metrics show Riken Vitamin outperforming the industry median in return on equity (ROE) at 11.86% and return on assets (ROA) at 8.31%. These figures suggest efficient use of equity and asset base to generate returns, which is a positive signal for investors. The company's revenue is concentrated in its core Food Processing segment, with no disclosed geographic diversification beyond Japan. This concentration may expose the company to regional economic fluctuations, though the stable demand for vitamins and food additives in Japan provides a degree of resilience. Looking ahead, Riken Vitamin is projected to maintain steady growth, with analysts forecasting revenue of ¥96 billion for the current fiscal year, compared to actual revenue of ¥95.58 billion. The company's operating cash flow of ¥7.89 billion and free cash flow of ¥5.01 billion support its ability to fund operations and reinvest in the business. Risk factors for Riken Vitamin include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position mitigate credit risk, while the absence of dilution pressure supports shareholder value preservation. Recent events include the publication of the latest financial results, which showed a net income of ¥9.39 billion and operating income of ¥7.66 billion. Analysts have set a mean EPS estimate of ¥213.55, below the last actual EPS of ¥310.06, indicating a potential earnings slowdown.